Antigen-specific T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antigen-specific T cell therapy, covering 2024-01-16 to 2024-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT [Phase 1, Phase 2]